Filters: Author is Paltiel, A David [Clear All Filters]
"Price, performance, and the FDA approval process: the example of home HIV testing." Medical decision making : an international journal of the Society for Medical Decision Making 30, no. 2 (2010): 217-23. Abstract
"Resource utilization and cost-effectiveness of counselor- vs. provider-based rapid point-of-care HIV screening in the emergency department." PloS one 6, no. 10 (2011): e25575. Abstract
"The potential impact of an HIV vaccine with rapidly waning protection on the epidemic in Southern Africa: examining the RV144 trial results." Vaccine 29, no. 36 (2011): 6107-12. Abstract
"Impact of obesity and knee osteoarthritis on morbidity and mortality in older Americans." Annals of internal medicine 154, no. 4 (2011): 217-26. Abstract
"The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South Africa." Journal of acquired immune deficiency syndromes (1999) 56, no. 1 (2011): 26-35. Abstract
"Scaling up circumcision programs in Southern Africa: the potential impact of gender disparities and changes in condom use behaviors on heterosexual HIV transmission." AIDS and behavior 15, no. 5 (2011): 938-48. Abstract
"Projected survival gains from revising state laws requiring written opt-in consent for HIV testing." Journal of general internal medicine 26, no. 6 (2011): 661-7. Abstract
"Dengue vector control strategies in an urban setting: an economic modelling assessment." Lancet 377, no. 9778 (2011): 1673-80. Abstract
"Medical device innovation--is "better" good enough?" The New England journal of medicine 365, no. 16 (2011): 1464-6.
"What is a modest public health impact?" Archives of internal medicine 172, no. 6 (2012): 521-2; author reply 522-3.
"Home HIV testing: good news but not a game changer." Annals of internal medicine 157, no. 10 (2012): 744-6.
"Routine HIV Screening in Portugal: Clinical Impact and Cost-Effectiveness." PloS one 8, no. 12 (2013): e84173. Abstract
"The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial." Drug and alcohol dependence 128, no. 1-2 (2013): 90-7. Abstract
"Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States." Annals of internal medicine 158, no. 2 (2013): 84-92. Abstract
"Cost-effectiveness of generic antiretroviral therapy--in response." Annals of internal medicine 158, no. 10 (2013): 776-7.
"Cost-effectiveness of generic antiretroviral therapy." Annals of internal medicine 158, no. 10 (2013): 776-7.
"Cost-effectiveness of HIV treatment as prevention in serodiscordant couples." The New England journal of medicine 369, no. 18 (2013): 1715-25. Abstract
"HIV Cure Strategies: How Good Must They Be to Improve on Current Antiretroviral Therapy?" PloS one 9, no. 11 (2014): e113031. Abstract
"Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: A model-based analysis in Côte d'Ivoire." Journal of acquired immune deficiency syndromes (1999) (2014). Abstract
"Paltiel Letter to the Editor." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2014).
"The survival benefits of antiretroviral therapy in South Africa." The Journal of infectious diseases 209, no. 4 (2014): 491-9. Abstract
"Mobile HIV Screening in Cape Town, South Africa: Clinical Impact, Cost and Cost-Effectiveness." PloS one 9, no. 1 (2014): e85197. Abstract
"Misinterpretation of HIV preexposure prophylaxis findings." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 59, no. 1 (2014): 139-41.
"The Clinical and Economic Impact of Point-of-Care CD4 Testing in Mozambique and Other Resource-Limited Settings: A Cost-Effectiveness Analysis." PLoS medicine 11, no. 9 (2014): e1001725. Abstract
"Reducing sexual violence by increasing the supply of toilets in khayelitsha, South Africa: a mathematical model." PloS one 10, no. 4 (2015): e0122244. Abstract
"The lifetime medical cost savings from preventing HIV in the United States." Medical care 53, no. 4 (2015): 293-301. Abstract
"Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection." The Journal of infectious diseases (2015). Abstract
"The Epi-TAF for Tenofovir Disoproxil Fumarate?" Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2015). Abstract
"The clinical role and cost-effectiveness of long-acting antiretroviral therapy." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2015). Abstract
"Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the US." HIV clinical trials (2015): 1945577115Y0000000009. Abstract
"A Flow-Based Model of the HIV Care Continuum in the United States." Journal of acquired immune deficiency syndromes (1999) (2017). Abstract
